2016 Publication listこのページを印刷する - 2016 Publication list

平成27年度（2016年4月―2017年3月）論文
  1. Furukawa M, Tao H, Tanaka T, Okabe K.　Mediastinal chyloma after lung cancer surgery: case report. J Cardiothorac Surg 11, 115, 2016
     
  2. Oishi, K., Aoe, K., Mimura, Y., Murata, Y., Sakamoto, K., Koutoku, W., Matsumoto, T., Ueoka, H., Yano, M. Survival from an acute exacerbation of idiopathic pulmonary fibrosis with or without direct hemoperfusion with a polymyxin B-immobilized fibercolumn: A retrospective analysis. Intern Med 55, 3551-9, 2016.
     
  3. Kunihiro Y, Okada M, Matsunaga N. Evaluation of a proper cutoff value on quantitative dual-energy perfusion CT for the assessment of acute pulmonary thromboembolism. Acta Radiol. doi: 10.1177/0284185116683577.
     
  4. Kunihiro Y, Kobayashi T, Tanaka N, Matsumoto T, Okada M, Kamiya M, Ueda K, Kawano H, Matsunaga N. High-resolution CT findings of primary lung cancer with cavitation:a comparison between adenocarcinoma and squamous cell carcinoma. Clin Radiol 71, 1126-31, 2016
     
  5. Tao H, Tanaka T, Hayashi T, Yoshida K, Furukawa M, Yoshiyama K, Okabe K. Influence of stapling the intersegmental planes on lung volume and function after segmentectomy. Interact Cardiovasc Thorac Surg 23, 548-52, 2016
     
  6. Oyama, Y., Enomoto, N., Suzukia, Y., Konoa, M., Fujisawa, T., Inuia, N., Nakamura, Y., Kuroishi, S., Yokomura, K., Toyoshima, M., Imokawa, S., Oishi, K., Watanabe, S., Kasahara, K., Baba, T., Ogura, T., Ishii, H., Watanabe, K., Nishioka, Y., Suda, T. Evaluation of urinary desmosines as a noninvasive diagnostic biomarker in patients with idiopathic pleuroparenchymal fibroelastosis (PPFE). Respir Med 123: 63-70, 2017
     
  7. Murakami J, Ueda K, Hayashi M, Kobayashi T, Kunihiro Y, Hamano K. Size-capacity mismatch in the lung: a novel predictor for complications after lung cancer surgery. J Surg Res 209, 131-138, 2017
     
  8. Tanaka N, Kunihiro Y, Kobayashi T, Yujiri T, Kido S, Ueda K, Matsunaga N. High-resolution CT findings of idiopathic pneumonia syndrome after haematopoietic stem cell transplantation:based on the updated concept of idiopathic pneumonia syndrome by the American Thoracic Society in 2011. Clin Radiol 71, 953-9, 2016
     
  9. Yamamoto N, Goto K, Nishio M, Chikamori K, Hida T, et al. Final overall survival in JO22903, A phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer. Int J Clin Oncol 22, 70-8, 2017.
     
  10. Nishio M, Goto K, Chikamori K, Hida T, Katakami N, et al. Analysis of EpidermalGrowth Factor ReceptorMutations in Serum Among Japanese Patients Treated With First-Line Erlotinib for Advanced Non-Small-Cell Lung Cancer. Clin Lung Cancer 17:24-9 e1, 2016
     
  1. Reck M, Rodríguez-Abreu D, Robinson AG, Hui R, Csőszi T, Fülöp A, Gottfried M, Peled N, Tafreshi A, Cuffe S, O’Brien M, Rao S, Hotta K, Leiby MA, Lubiniecki GM, Shentu Y, Rangwala R, Brahmer JR; KEYNOTE-024 Investigators (incl. Aoe, K.). Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer. N Engl J Med 375, 1823-1833, 2016
     
  2. Kato K, Gemba K, Fujimoto N, Aoe K, Takeshima Y, Inai K, Kishimoto T. Pleural irregularities and mediastinal pleural involvement in early stages of malignant pleural mesothelioma and benign asbestos pleural effusion. Eur J Radiol 85, 1594-600, 2016
     
  3. Ohashi K, Hotta K, Hirata T, Aoe K, Kozuki T, Ninomiya K, Kayatani H, Yanai H, Toyooka S, Hinotsu S, Takata M, Kiura K. Trastuzumab Emtansine in HER2+ Recurrent Metastatic Non-Small-Cell Lung Cancer: Study Protocol. Clin Lung Cancer 18, 92–5, 2017
     
  4. Kato K, Gemba K, Fujimoto N, Aoe K, Takeshima Y, Inai K, Kishimoto T. Fatal pleural mesothelioma in Japan (2003-2008): Evaluation of computed tomography findings. Jpn J Radiol 34, 432-8, 2016
     
  5. Takayama K, Katakami N, Yokoyama T, Atagi S, Yoshimori K, Kagamu H, Saito H, Takiguchi Y, Aoe K, Koyama A, Komura N, Eguchi K. Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial. Support Care Cancer 24: 3495-505, 2016
     
  6. Takayama K, Atagi S, Imamura F, Tanaka H, Minato K, Harada T, Katakami N, Yokoyama T, Yoshimori K, Takiguchi Y, Hataji O, Takeda Y, Aoe K, Kim YH, Yokota S, Tabeta H, Tomii K, Ohashi Y, Eguchi K, Watanabe K. Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study. Support Care Cancer 24, 3495-505, 2016
     
  7. 村田順之、青江啓介、宇都宮利彰、坂本健次、大石景士、神徳済、近森研一、前田忠士、岡部和倫、村上知之、矢野雅文、上岡博．胸水ADAが高値を示し、結核性胸膜炎との鑑別を要した胸膜原発悪性リンパ腫の一例. 山口医学2016；6：161-166
    　
  8. 青江啓介．肺がん治療における免疫療法の位置づけ～免疫チェックポイント阻害薬とは．Oncology Nurse 9: 45-47, 2016
     
  9. 青江啓介．胸膜プラークがないものの肺内アスベスト小体が多数認められた胸膜中皮腫の症例．アスベスト関連疾患日常診療ガイド（増補改訂3版）、独立行政法人労働者健康福祉機構編、労働調査会、東京 2016, 61-62
     
  10. 重症心身障害児（者）におけるおむつカバー代用としての腰部防水シーツ装着がおむつ内の温湿度に及ぼす影響．宇部フロンティア大学　看護学ジャーナル 2016
     
  11. 青江啓介．悪性胸膜中皮腫．補助診断マーカー．EBM手法による肺癌診療ガイドライン（悪性胸膜中皮腫、胸腺腫瘍含む）、日本肺癌学会編、金原出版株式会社、2016, 250-251
ページトップへ